Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schaffer

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
American Heart Journal|April 25, 2007
Prospective assessment after pediatric cardiac ablation: fate of intracardiac structure and function, as assessed by serial echocardiographyGeorge F Van Hare, Steven D Colan, Harold Javitz, et al.
The American Journal of Cardiology|November 25, 2010
Axillary versus infraclavicular placement for endocardial heart rhythm devices in patients with pediatric and congenital heart diseaseChristopher M Rausch, Benjamin H Hughes, Martin Runciman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2015
Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman DiseaseCorey Casper, Shalini Chaturvedi, Nikhil Munshi, et al.
Journal of Cardiovascular Electrophysiology|July 15, 2004
Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomesGeorge F Van Hare, Harold Javitz, Dorit Carmelli, et al.
The Oncologist|October 16, 2025
Pemigatinib for previously treated metastatic or unresectable central nervous system tumors with fibroblast growth factor receptor mutations or rearrangements: FIGHT-207 resultsIben Spanggaard, Marc Matrana, Caio Rocha Lima, et al.
Heart Rhythm|April 27, 2005
Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardiaGeorge F Van Hare, Harold Javitz, Dorit Carmelli, et al.
Pacing and Clinical Electrophysiology : PACE|May 7, 2002
Prospective assessment after pediatric cardiac ablation: design and implementation of the multicenter studyGeorge F Van Hare, Dorit Carmelli, W Mcfate Smith, et al.
Cancer Medicine|November 18, 2021
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trialSriram Balasubramanian, Brendan Hodkinson, Stephen J Schuster, et al.
Molecular Oncology|October 21, 2022
Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real-world genomic datasetsSantiago Viteri, Anna Minchom, Lyudmila Bazhenova, et al.
Disaster Medicine and Public Health Preparedness|March 8, 2019
Influenza A (H3) Outbreak at a Hurricane Harvey Megashelter in Harris County, Texas: Successes and Challenges in Disease Identification and Control Measure ImplementationLeann Liu, Aisha Haynie, Sherry Jin, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
American Heart Journal|April 25, 2007
Prospective assessment after pediatric cardiac ablation: fate of intracardiac structure and function, as assessed by serial echocardiographyGeorge F Van Hare, Steven D Colan, Harold Javitz, et al.
The American Journal of Cardiology|November 25, 2010
Axillary versus infraclavicular placement for endocardial heart rhythm devices in patients with pediatric and congenital heart diseaseChristopher M Rausch, Benjamin H Hughes, Martin Runciman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2015
Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman DiseaseCorey Casper, Shalini Chaturvedi, Nikhil Munshi, et al.
Journal of Cardiovascular Electrophysiology|July 15, 2004
Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomesGeorge F Van Hare, Harold Javitz, Dorit Carmelli, et al.
The Oncologist|October 16, 2025
Pemigatinib for previously treated metastatic or unresectable central nervous system tumors with fibroblast growth factor receptor mutations or rearrangements: FIGHT-207 resultsIben Spanggaard, Marc Matrana, Caio Rocha Lima, et al.
Heart Rhythm|April 27, 2005
Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardiaGeorge F Van Hare, Harold Javitz, Dorit Carmelli, et al.
Pacing and Clinical Electrophysiology : PACE|May 7, 2002
Prospective assessment after pediatric cardiac ablation: design and implementation of the multicenter studyGeorge F Van Hare, Dorit Carmelli, W Mcfate Smith, et al.
Cancer Medicine|November 18, 2021
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trialSriram Balasubramanian, Brendan Hodkinson, Stephen J Schuster, et al.
Molecular Oncology|October 21, 2022
Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real-world genomic datasetsSantiago Viteri, Anna Minchom, Lyudmila Bazhenova, et al.
Disaster Medicine and Public Health Preparedness|March 8, 2019
Influenza A (H3) Outbreak at a Hurricane Harvey Megashelter in Harris County, Texas: Successes and Challenges in Disease Identification and Control Measure ImplementationLeann Liu, Aisha Haynie, Sherry Jin, et al.
Pageof 6